Global Coagulation Reagents Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2022 –2029 |
Market Size (Base Year) |
USD 2,738.84 Million |
Market Size (Forecast Year) |
USD 6,176.57 Million |
CAGR |
|
Major Markets Players |
全球凝血试剂市场,按测试类型(APTT、D-二聚体、纤维蛋白原、凝血酶原、其他)、技术(机械、电化学、光学、其他)、最终用途(医院、研究机构、诊断中心、其他)划分 - 行业趋势和预测到 2029 年。
凝血试剂市场分析及规模
试剂主要用于快速诊断因血液凝固/纤维蛋白溶解异常引起的各种疾病,以及用于测量凝血/纤维蛋白溶解因子、激活剂和/或抑制剂的更可靠的试剂,这些试剂有助于确定治疗方案。具有高稳定性和成本效益的凝血试剂适用于各种临床化学分析设备。还研究和开发了基于凝血的体外诊断设备的客户专用试剂。某些型号可溶于水性缓冲液或水,旨在用于凝血酶凝血时间测试中的人体血浆。
Data Bridge Market Research 分析,凝血试剂市场在 2021 年为 27.3884 亿美元,预计到 2029 年将达到 61.7657 亿美元,在 2022 年至 2029 年的预测期内复合年增长率为 10.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
凝血试剂市场范围和细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
测试类型(APTT、D-二聚体、纤维蛋白原、凝血酶原、其他)、技术(机械、电化学、光学、其他)、最终用途(医院、研究机构、诊断中心、其他) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
涵盖的市场参与者 |
Sclavo Vaccines Association (Italy), Randox Laboratories Ltd. (U.K.), BIO DIAGNOSTICS Ltd. (U.K.), Robonik India (India), Sekisui Diagnostics (U.S.), Haemonetics Corporation (U.S.), Agappediagnostics Ltd. (India), Rayto Life and Analytical Sciences Co. Ltd. (China), China BeiJing Steellex Scientific Instrument Company (China), Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Gesan Production (Italy), Goldsite Diagnostics Inc. (China), Grifols S.A (Spain), Diagnostica Stago (France), High Technology, Inc. (U.S.), Bio Group Medical System (Italy), Zircon Biotech Co., Ltd (China), McGraw Hill (U.S.) |
Market Opportunities |
|
Market Definition
Coagulation test systems consist of an instrument as well as a reagent (thromboplastin or partial thromboplastin). Coagulation tests assess the ability of blood to clot as well as the time it takes to clot. Tests can assist doctors in determining the likelihood of excessive bleeding or clot formation (thrombosis) anywhere in the blood vessels. Coagulation reagents are excellent for measuring large areas in order to detect abnormal results accurately, and they have strong correlations with standard methods, ensuring that results are reliable.
Global Coagulation Reagents Market Dynamics
Drivers
- Rising incidence of cardiovascular diseases
Rising incidence of cardiovascular illnesses and blood disorders is likely to have a substantial impact on the coagulation reagents market in the forecast period of 2022 to 2029. Cardiovascular diseases (CVDs) are becoming more prevalent in the Indian population, with a trend toward younger age groups. It is known to play a significant role in burden of diseases. A number of studies have been conducted to determine the prevalence of CVDs, and it has been discovered that they are widespread in India, with regional variations.
Another important factor driving the expanding use of blood coagulation analyzers is the growing senior population, rising healthcare costs, technological developments, and rising obesity rates. Emerging markets and the growing reagent rental business, on the other hand, will provide significant chances for the coagulation reagents market to grow throughout the forecast period.
- New innovative technologies
The introduction of innovative analyzers by key market players that are tiny and simple to integrate has risen a demand for such analyzers to be widely used in a variety of medical facilities. Furthermore, the increasing awareness of the health-care system in many parts of the world is increasing demand for such analyzers. The overall industry is also being propelled by rapid advancements and optimization in testing facilities.
- Demand for healthcare funds
Proliferation of innovative health care facilities, treatment centres, laboratory facilities, and academic institutions that have followed has resulted in a significant increase in demand for this type of analyzer. Demand for these analyzers is also increasing due to an increase in the number of heart attacks and blood diseases. Patients were able to utilise these analyzers at home to assess their coagulation state due to their convenience of use and performance features. The above-mentioned factors are expected to enhance worldwide market growth.
Opportunities
- Government initiatives
The initiatives by the government and corporations resulted in people going for early diagnosis. For instance, Boehringer Ingelheim hosted a symposium in November 2014 to discuss treatment safety and efficacy in acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). As a result, the demand for haematological tests has increased, and the demand for coagulation reagents also increasing.
Restraints/Challenges
High cost, strict and time-consuming regulatory processes will obstruct the market's growth rate. One of the major disadvantages of using chemical coagulation is the large amount of residual sludge produced at the end of the process. Electrocoagulation generates about half the sludge that chemical coagulation does. Several countries now have strict legislation in place to limit the environmental impact of such residuals.
This coagulation reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the coagulation reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Coagulation Reagents Market
The sudden increasing cases of COVID-19 have caused increased consciousness of the population across the globe towards health. People are avoiding the products that do not come under essential commodities owing to the demand for these analyzers has been decreased. Moreover, the reduced supply chain affected the production and supply of the coagulation analyzer. Furthermore, due to disease severity and poor diagnosis of COVID-19 coagulation parameters are associated with it and is considered to be a risk factor for COVID-19.
Global Coagulation Reagents Market Scope
The coagulation reagents market is segmented on the basis of test type, technology and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- APTT
- D-Dimer
- Fibrinogen
- Prothrombin
- Others
Technology
- Mechanical
- Electrochemical
- Optical
- Others
End Use
- Hospitals
- Research Institutes
- Diagnostic Centers
- Others
Coagulation Reagents Market Regional Analysis/Insights
The coagulation reagents market is analysed and market size insights and trends are provided by country, test type, technology and end use as referenced above.
The countries covered in the coagulation reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the coagulation reagents market due to the increasing government initiatives for the development of healthcare infrastructure in the region and rising incidence of blood-related disorders, increasing prevalence of disorders.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of hospitals, health centers and clinics combined with highly skilled professionals to provide useful, appropriate and safe healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Coagulation Reagents Market Share Analysis
凝血试剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对凝血试剂市场的关注有关。
凝血试剂市场的一些主要参与者包括:
- Sclavo 疫苗协会(意大利)
- Randox Laboratories Ltd.(英国)
- BIO DIAGNOSTICS 有限公司(英国)
- Robonik India(印度)
- Sekisui Diagnostics(美国)
- Haemonetics 公司 (美国)
- Agappediagnostics Ltd. (印度)
- 瑞拓生命分析科学有限公司 (中国)
- 中国北京世鼎科学仪器有限公司 (中国)
- 西门子(德国)
- F. Hoffmann-La Roche Ltd.(瑞士)
- Gesan Production(意大利)
- 金点诊断股份有限公司 (中国)
- Grifols SA(西班牙)
- Diagnostica Stago(法国)
- High Technology, Inc.(美国)
- Bio Group Medical System(意大利)
- 锆康生物科技股份有限公司 (中国)
- 麦格劳·希尔(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.